Global Cord Blood
CORBF
$0.71
Share price
29.09%
Change (1 day)
-52.67%
Change (1 year)
Categories
Earnings for Global Cord Blood (CORBF)
Earnings in 2022 (TTM): $95.06 Million USD
According to Global Cord Blood's latest financial reports the company's current earnings are $0.19 Billion USD. In 2021 the company made an earning of $95.26 Million USD, an increase over its 2020 earnings that were of $82.28 Million USD. The earnings displayed on this page is the company's Pretax Income.
Earnings history for Global Cord Blood from 2008 to 2022
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2022 (TTM)  | $95.06 M | -0.22% |
| 2021 | $95.26 M | 15.78% |
| 2020 | $82.28 M | 10.11% |
| 2019 | $74.72 M | 46.83% |
| 2018 | $50.89 M | 5.31% |
| 2017 | $48.32 M | 22.57% |
| 2016 | $39.42 M | -3.68% |
| 2015 | $40.93 M | -6.8% |
| 2014 | $43.92 M | 8.79% |
| 2013 | $40.37 M | 19.85% |
| 2012 | $33.68 M | 39.37% |
| 2011 | $24.16 M | 34.18% |
| 2010 | $18.01 M | 124.91% |
| 2009 | $8 M | -563.02% |
| 2008 | -$1.73 Million |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Cryo-Cell CCEL | $4.64 M | -95.11% | 🇺🇸 USA |
 NeoGenomics
NEO | -$72.11 Million | -175.85% | 🇺🇸 USA |
 RadNet RDNT | $89 M | -6.37% | 🇺🇸 USA |
 National Healthcare
NHC | $0.15 B | 58.44% | 🇺🇸 USA |